LexisNexis® Legal Newsroom
New Jersey Jury Awards $2M In 1 Accutane Case, Finds For Defense In 2 Others

ATLANTIC CITY, N.J. - (Mealey's) A New Jersey state court jury on April 8 awarded a plaintiff $2.1 million after finding that Hoffman-La Roche Inc.'s acne drug Accutane was a substantial factor in causing her inflammatory bowel disease (IBD) and that the company failed to adequately warn her...

$11.8 Million New Jersey Accutane Verdicts Vacated By Florida Ruling On Proximate Causation

TRENTON, N.J. - (Mealey's) A New Jersey state appeals panel on Aug. 7 vacated an $11.8 million Accutane verdict after finding that under controlling Florida case law, three plaintiffs had not established that a failure to warn about the risk of inflammatory bowel disease (IBD) by defendant Hoffman...

New Jersey Jury Awards $1.58M In Retrial Of Accutane Bowel Injury Case

ATLANTIC CITY, N.J. — (Mealey’s) A New Jersey state court jury on March 11 found that Hoffman-La Roche failed to adequately warn that its former acne drug Accutane could cause ulcerative colitis and awarded the plaintiff $1,587,928 for past medical expenses and for pain and suffering ( Kamie...

$2M N.J. Accutane Verdict Reversed, 2 Defense Verdicts Affirmed On Appeal

TRENTON, N.J. — (Mealey’s) A New Jersey appeals panel on Aug. 4 vacated a $2,125,617 Accutane bowel injury verdict and affirmed defense verdicts in two other cases tried at the same time ( Gillian Gaghan v. Hoffman-La Roche Inc., et al. , Nos. A-2717-11T2, A-3211-11T2 and A-3217-11T2, N.J...